At the news
? NEUTRALIMPACT 3/10 EFFECT filed Nov 12, 2026 at 00:15 ET
The SEC declared effective Purple Biotech Ltd.'s shelf registration statement on Form F-3 (File No. 333-296088) on November 10, 2026. This allows the company to offer and sell securities from time to time, creating potential dilution overhang given the company's small market cap of $2M.
- Effectiveness date: November 10, 2026
- Registration statement on Form F-3 (File No. 333-296088)
- Company market cap: $2M
- Normal daily move: 4.3%
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access